Your browser doesn't support javascript.
loading
Innovative nanochemotherapy for overcoming cancer multidrug resistance.
Tan, Hong; Zhang, Mengyu; Wang, Yuqing; Timashev, Peter; Zhang, Yuanyuan; Zhang, Shouwen; Liang, Xing-Jie; Li, Fangzhou.
Afiliación
  • Tan H; National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Bio-targeting Theranostics, Guangxi Medical University, Nanning, Guang
  • Zhang M; National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Bio-targeting Theranostics, Guangxi Medical University, Nanning, Guang
  • Wang Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, People's Republic of China.
  • Timashev P; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Zhang Y; Laboratory of Clinical Smart Nanotechnologies, Institute for Regenerative Medicine, Sechenov University, Moscow 119991, Russia.
  • Zhang S; Laboratory of Clinical Smart Nanotechnologies, Institute for Regenerative Medicine, Sechenov University, Moscow 119991, Russia.
  • Liang XJ; Neurophysiology Department, Beijing Chao Yang Emergency Medical Center, Beijing 100122, People's Republic of China.
  • Li F; National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Bio-targeting Theranostics, Guangxi Medical University, Nanning, Guang
Nanotechnology ; 33(5)2021 Nov 12.
Article en En | MEDLINE | ID: mdl-34700307

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Nanomedicina / Sistema de Administración de Fármacos con Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Nanotechnology Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Nanomedicina / Sistema de Administración de Fármacos con Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Nanotechnology Año: 2021 Tipo del documento: Article